Talphera (FRA:R5XA) Beginning Cash Position : €5.26 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Talphera Beginning Cash Position?

Talphera's Beginning Cash Position for the quarter that ended in Mar. 2024 was €5.26 Mil.

Talphera's quarterly Beginning Cash Position increased from Sep. 2023 (€6.94 Mil) to Dec. 2023 (€12.28 Mil) but then declined from Dec. 2023 (€12.28 Mil) to Mar. 2024 (€5.26 Mil).

Talphera's annual Beginning Cash Position declined from Dec. 2021 (€24.14 Mil) to Dec. 2022 (€11.95 Mil) but then increased from Dec. 2022 (€11.95 Mil) to Dec. 2023 (€18.59 Mil).

Talphera Beginning Cash Position Historical Data

The historical data trend for Talphera's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Talphera Beginning Cash Position Chart

Talphera Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

79.18

12.07

24.14

11.95

18.59

Talphera Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															18.94	12.32	6.94	12.28	5.26

Talphera Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Talphera Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Talphera's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Talphera (FRA:R5XA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Talphera Inc (FRA:R5XA) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

TLPH:USA

Address

25821 Industrial Boulevard, Suite 400, Hayward, CA, USA, 94545

Website

https://www.acelrx.com

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Its product portfolio includes Niyad that is a lyophilized formulation of nafamostat. It is also developing two pre-filled syringes, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.

Talphera (FRA:R5XA) Headlines

No Headlines